Anti-JCV antibody index does not change during ocrelizumab-treatment.
Torge RempeAaron CarlsonAugusto MiravalleTirisham Victoria GyangPublished in: Multiple sclerosis journal - experimental, translational and clinical (2020)
Treatment with ocrelizumab is not associated with an increase in anti-JCV AI titers.